Metraipolis › archive › dc_e26d1ca330a0

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II… — Europe PMC PMID:41213710

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41213710
DOI
10.1136/bmjopen-2025-100082
License (as archived)
solo-consultazione
Archived
2026-11-08T17:10:43.895Z
SHA-256 of the archived text
edc38702fcc85ecf13b8189320fc6082f9798675e8ff11c35d17a4e7a826c95c
Stable URL of this page
https://metraipolis.com/documento/dc_e26d1ca330a0

How to cite

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II… — Europe PMC PMID:41213710 — Europe PMC (en), https://europepmc.org/article/MED/41213710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e26d1ca330a0 (Metraipolis archive dc_e26d1ca330a0, sha256 edc38702fcc85ecf13b8189320fc6082f9798675e8ff11c35d17a4e7a826c95c)
BibTeX
@misc{dce26d1ca330a0,
  title = {Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II… — Europe PMC PMID:41213710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41213710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e26d1ca330a0; sha256 edc38702fcc85ecf13b8189320fc6082f9798675e8ff11c35d17a4e7a826c95c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41213710. Agents can read the archived copy with the MCP tool read_document.